File Download
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.3390/cancers12092545
- Scopus: eid_2-s2.0-85090277642
- PMID: 32906798
- WOS: WOS:000580791400001
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: FANCD2 Confers a Malignant Phenotype in Esophageal Squamous Cell Carcinoma by Regulating Cell Cycle Progression
Title | FANCD2 Confers a Malignant Phenotype in Esophageal Squamous Cell Carcinoma by Regulating Cell Cycle Progression |
---|---|
Authors | |
Keywords | FANCD2 esophageal squamous cell carcinoma cell cycle ubiquitination |
Issue Date | 2020 |
Publisher | MDPI AG. The Journal's web site is located at http://www.mdpi.com/journal/cancers/ |
Citation | Cancers, 2020, v. 12 n. 9, article no. 2545 How to Cite? |
Abstract | Fanconi anemia patients with germline genetic defects in FANCD2 are highly susceptible to cancers. Esophageal squamous cell carcinoma (ESCC) is a deadly cancer. Little is known about the function of FANCD2 in ESCC. For detailed molecular and mechanistic insights on the functional role of FANCD2 in ESCC, in vivo and in vitro assays and RNA sequencing approaches were used. Utilizing Clustered Regularly Interspaced Short Palindromic Repeat (CRISPR) technology, FANCD2 knockout models were established to examine the functional impact in mouse models for tumor growth and metastasis and in vitro assays for cell growth, cell cycle, and cellular localization. Our RNA sequence analyses were integrated with public datasets. FANCD2 confers a malignant phenotype in ESCC. FANCD2 is significantly upregulated in ESCC tumors, as compared to normal counterparts. Depletion of FANCD2 protein expression significantly suppresses the cancer cell proliferation and tumor colony formation and metastasis potential, as well as cell cycle progression, by involving cyclin-CDK and ATR/ATM signaling. FANCD2 translocates from the nucleus to the cytoplasm during cell cycle progression. We provide evidence of a novel role of FANCD2 in ESCC tumor progression and its potential usefulness as a biomarker for ESCC disease management. |
Persistent Identifier | http://hdl.handle.net/10722/287351 |
ISSN | 2023 Impact Factor: 4.5 2023 SCImago Journal Rankings: 1.391 |
PubMed Central ID | |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lei, CL | - |
dc.contributor.author | Yu, VZ | - |
dc.contributor.author | Ko, JMY | - |
dc.contributor.author | Ning, L | - |
dc.contributor.author | Lung, ML | - |
dc.date.accessioned | 2020-09-22T02:59:44Z | - |
dc.date.available | 2020-09-22T02:59:44Z | - |
dc.date.issued | 2020 | - |
dc.identifier.citation | Cancers, 2020, v. 12 n. 9, article no. 2545 | - |
dc.identifier.issn | 2072-6694 | - |
dc.identifier.uri | http://hdl.handle.net/10722/287351 | - |
dc.description.abstract | Fanconi anemia patients with germline genetic defects in FANCD2 are highly susceptible to cancers. Esophageal squamous cell carcinoma (ESCC) is a deadly cancer. Little is known about the function of FANCD2 in ESCC. For detailed molecular and mechanistic insights on the functional role of FANCD2 in ESCC, in vivo and in vitro assays and RNA sequencing approaches were used. Utilizing Clustered Regularly Interspaced Short Palindromic Repeat (CRISPR) technology, FANCD2 knockout models were established to examine the functional impact in mouse models for tumor growth and metastasis and in vitro assays for cell growth, cell cycle, and cellular localization. Our RNA sequence analyses were integrated with public datasets. FANCD2 confers a malignant phenotype in ESCC. FANCD2 is significantly upregulated in ESCC tumors, as compared to normal counterparts. Depletion of FANCD2 protein expression significantly suppresses the cancer cell proliferation and tumor colony formation and metastasis potential, as well as cell cycle progression, by involving cyclin-CDK and ATR/ATM signaling. FANCD2 translocates from the nucleus to the cytoplasm during cell cycle progression. We provide evidence of a novel role of FANCD2 in ESCC tumor progression and its potential usefulness as a biomarker for ESCC disease management. | - |
dc.language | eng | - |
dc.publisher | MDPI AG. The Journal's web site is located at http://www.mdpi.com/journal/cancers/ | - |
dc.relation.ispartof | Cancers | - |
dc.rights | This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. | - |
dc.subject | FANCD2 | - |
dc.subject | esophageal squamous cell carcinoma | - |
dc.subject | cell cycle | - |
dc.subject | ubiquitination | - |
dc.title | FANCD2 Confers a Malignant Phenotype in Esophageal Squamous Cell Carcinoma by Regulating Cell Cycle Progression | - |
dc.type | Article | - |
dc.identifier.email | Yu, VZ: zvyu@hku.hk | - |
dc.identifier.email | Ko, JMY: joko@hku.hk | - |
dc.identifier.email | Ning, L: lvwen@HKUCC-COM.hku.hk | - |
dc.identifier.email | Lung, ML: mlilung@hku.hk | - |
dc.identifier.authority | Ko, JMY=rp02011 | - |
dc.identifier.authority | Lung, ML=rp00300 | - |
dc.description.nature | published_or_final_version | - |
dc.identifier.doi | 10.3390/cancers12092545 | - |
dc.identifier.pmid | 32906798 | - |
dc.identifier.pmcid | PMC7565464 | - |
dc.identifier.scopus | eid_2-s2.0-85090277642 | - |
dc.identifier.hkuros | 314496 | - |
dc.identifier.volume | 12 | - |
dc.identifier.issue | 9 | - |
dc.identifier.spage | article no. 2545 | - |
dc.identifier.epage | article no. 2545 | - |
dc.identifier.isi | WOS:000580791400001 | - |
dc.publisher.place | Switzerland | - |
dc.identifier.issnl | 2072-6694 | - |